MGM vs STRO · P/E 64, rev $17.54B vs rev $62.0M
MGM Resorts International (MGM) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported MGM revenue for 2025-12-31 was $17.54B. Net income was $205.9M. Revenue was up 1.7% from 2024-12-31 to 2025-12-31. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
MGM currently screens at market cap $12.01B and trailing P/E 64.3. STRO currently screens at market cap $470.8M.
Not investment advice. Open the MGM and STRO stock pages for the full models.
Not investment advice.